A detailed history of Temasek Holdings (Private) LTD transactions in Guardant Health, Inc. stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 2,088,194 shares of GH stock, worth $74.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,088,194
Holding current value
$74.2 Million
% of portfolio
0.2%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.29 $46.6 Million - $75.8 Million
2,088,194 New
2,088,194 $47.9 Million
Q2 2024

Aug 14, 2024

SELL
$16.07 - $31.84 $5.82 Million - $11.5 Million
-362,070 Reduced 8.81%
3,749,102 $108 Million
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $7.5 Million - $11.8 Million
437,929 Added 11.92%
4,111,172 $84.8 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $7.5 Million - $11.6 Million
-290,629 Reduced 7.33%
3,673,243 $109 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $6.27 Million - $11.4 Million
299,510 Added 8.17%
3,963,872 $142 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $46.8 Million - $69 Million
2,043,573 Added 126.09%
3,664,362 $85.9 Million
Q3 2022

May 15, 2023

BUY
$43.66 - $61.0 $339,762 - $474,702
7,782 Added 0.48%
1,620,789 $87.2 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $339,762 - $474,702
7,782 Added 0.48%
1,620,789 $87.2 Million
Q1 2022

May 15, 2023

SELL
$48.25 - $100.49 $375,481 - $782,013
-7,782 Reduced 0.48%
1,613,007 $107 Million
Q4 2018

Feb 14, 2019

BUY
$29.2 - $46.1 $47.1 Million - $74.4 Million
1,613,007 New
1,613,007 $60.6 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.63B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.